Home
Scholarly Works
A randomized phase II trial of a new...
Conference

A randomized phase II trial of a new anticoagulant, apixaban, in metastatic cancer

Authors

Levine MN; Deitchman D; Julian J; Liebman H; Escalante C; O'Brien MC; Ramirez L; Weise-Kelly L; Solymoss S

Volume

27

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

May 20, 2009

Name of conference

45th Annual Meeting of the American-Society-of-Clinical-Oncology

Conference place

FL, Orlando

Conference start date

May 29, 2009

Conference end date

June 2, 2009

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

15

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team